← Back to Clinical Trials
Recruiting NCT06323330

NCT06323330 Music Therapy for Rehabilitation in Post-stroke Non-fluent Aphasia: the Indian Adaptation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06323330
Status Recruiting
Phase
Sponsor All India Institute of Medical Sciences
Condition Stroke Rehabilitation
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2024-06-01
Primary Completion 2026-10-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
Speech rehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2024-06-01 with a primary completion date of 2026-10-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this Interventional Study is to develop and test the Indian Adaptation of Melodic Intonation Therapy (MIT) for Indian patients in with post-stroke Non-Fluent Aphasia (PSNFA). The main question\[s\] it aims to answer are: • To develop the MIT Indian Adaptation tool and check its feasibility • To compare the MIT with standard speech rehabilitation in patient with PSNFA. Participants will undergo Speech Rehabilitation according to the developed module and the standard treatment will be given in the comparator arm. The speech recovery at 12 weeks will be compared in both treatment arms.

Eligibility Criteria

Inclusion Criteria: All of the following 1. Age ≥18 years of age 2. Stroke with non-fluent aphasia, within one year of ictus 3. Imaging evidence suggestive of ischemic or hemorrhagic stroke of dominant hemisphere 4. Patient is alert and able to follow simple commands (should not have global aphasia) 5. Motivated caregiver 6. Informed and signed consent Exclusion Criteria: Any of the following: 1. Patients with a history of a previous stroke other than the index event, which can explain the aphasia. 2. Any clinical condition (e.g., short life expectancy, coexisting disease) or other characteristics that preclude appropriate follow-up in the study (e.g., distant residence, no family support) 3. Patients participating in any therapeutic intervention clinical trials evaluating poststroke recovery 4. Use of psychotropic drugs that interfere with patient evaluation

Contact & Investigator

Central Contact

Deepti Vibha

✉ deeptivibha@aiims.edu

📞 +91-9868398263

Frequently Asked Questions

Who can join the NCT06323330 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Stroke Rehabilitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06323330 currently recruiting?

Yes, NCT06323330 is actively recruiting participants. Contact the research team at deeptivibha@aiims.edu for enrollment information.

Where is the NCT06323330 trial being conducted?

This trial is being conducted at New Delhi, India, New Delhi, India, Delhi, India.

Who is sponsoring the NCT06323330 clinical trial?

NCT06323330 is sponsored by All India Institute of Medical Sciences. The trial plans to enroll 60 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology